跳至主要内容
临床试验/NCT01425697
NCT01425697已完成不适用

Randomized,Prospective Evaluation of 2% Chlorhexidine Gluconate Cloths to Reduce Surgical Site Infections in Cardiothoracic Surgery Patients

University of Rochester5 个研究点 分布在 1 个国家目标入组 739 人开始时间: 2008年11月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
739
试验地点
5
主要终点
Surgical site infections

研究概览

简要总结

The purpose of the study is to see if using 2% Chlorhexidine cloths will reduce surgical site infections in patients having elective cardiac surgery.

详细描述

A randomized, prospective study utilizing 2% Chlorhexidine cloths to evaluate the product's effectiveness in reducing surgical site infections in elective cardiothoracic surgery patients. Sage 2% chlorhexidine cloths are approved by the Food and Drug Administration (FDA) for preparation of skin prior to surgery.

The study hypothesis is that the preoperative surgical preparation with 2% chlorhexidine cloths, which leaves chlorhexidine on the skin, will reduce surgical site infections by 50% as compared to current standard procedure.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Elective cardiothoracic surgery patients > 18 years old.
  • Informed consent obtained

排除标准

  • Any current known allergies to chlorhexidine gluconate
  • Currently taking any oral or topical antibiotics
  • Any active skin rashes or breaks in the skin on areas to be treated with chlorhexidine gluconate
  • A current active skin disease or inflammatory skin condition, known pre-existing skin infection, including contact dermatitis that is currently being treated with an antibiotic
  • Any medical condition or use of any medications that in the opinion of the Principal Investigator preclude participation.
  • Unwillingness or failure to fulfill requirements of the study

结局指标

主要结局

Surgical site infections

时间窗: Through 90 days post procedure

Subjects will be assessed at 30 days and 90 days post operatively for any surgical site infection

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Michael Ackerman

Principal Investigator

University of Rochester

研究点 (5)

Loading locations...

相似试验